BridgeMD
Compares treatment options for Cataract and IOL Surgery
Official title Clareon PanOptix Versus AcrySof PanOptix : Prospective Study Comparing Contrast Sensitivity
ClinicalTrials.gov ID: NCT07158177
What this study is testing
- What it's testing
- Retrospective, comparative, interventional, randomized, single-center study, contralateral (the patient's 2 eyes will be implanted: 1 CPO and the other APO) Patients presenting for cataract surgery with a request for presbyopia correction and managed as part of routine clinical practice. The main aim of the study is to demonstrate that contrast sensitivity is better with the Clareon PanOptix (CPO) intraocular lens (IOL) compared with the AcrySof PanOptix (APO) IOL 3 months after implantation.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients ≥ 18 years of age
- Patients presenting for cataract surgery in routine clinical practice and eligible for multifocal IOL implantation (toric and non-toric)
- Patients with grade 2/3 cataract density and comparable visual acuity in both eyes
- Patient with a pregnancy test (negative pregnancy test), if applicable
- Patient with signed consent to participate in the study
You likely can't join if
- Children \< 18 years of age
- Pregnancy or breast-feeding in progress or planned during the study.
- History of anterior (cornea, anterior chamber, sulcus) or posterior (uveal, vitreoretinal) segment pathology, including retinal vascular occlusive...
- Any inflammation of the anterior or posterior segment, whatever the etiology, and/or history of any disease with intraocular inflammatory...
- Clinically significant corneal pathology (epithelial, stromal and/or endothelial) that could have an impact on visual results.
- Clinically significant moderate or severe dry eye that could affect study measurements.
See the full eligibility criteria
- Patients ≥ 18 years of age
- Patients presenting for cataract surgery in routine clinical practice and eligible for multifocal IOL implantation (toric and non-toric)
- Patients with grade 2/3 cataract density and comparable visual acuity in both eyes
- Patient with a pregnancy test (negative pregnancy test), if applicable
- Patient with signed consent to participate in the study
- Patient affiliated to a social security scheme or entitled beneficiary
- Children \< 18 years of age
- Pregnancy or breast-feeding in progress or planned during the study.
- History of anterior (cornea, anterior chamber, sulcus) or posterior (uveal, vitreoretinal) segment pathology, including retinal vascular occlusive disease, retinal detachment or peripheral retinal laser...
- Any inflammation of the anterior or posterior segment, whatever the etiology, and/or history of any disease with intraocular inflammatory repercussions.
- Clinically significant corneal pathology (epithelial, stromal and/or endothelial) that could have an impact on visual results.
- Clinically significant moderate or severe dry eye that could affect study measurements.
- History of intraocular or corneal surgery (refractive or trauma-related).
- Presence or history of amblyopia or monofixation syndrome.
- people with conditions that increase the risk of zonular disruption during the phacoemulsification procedure that may affect the centration or postoperative orientation of the IOL.
- Any other planned eye surgery, including, but not limited to, limbal relaxing incision (LRI)/astigmatic keratotomy and laser refractive surgery (LASIK).
- Irregular astigmatism identified by corneal topography
- Patients under guardianship, curatorship or safeguard of justice, as well as pregnant or breast-feeding women (article L1121-5 of the CSP).1.1
- Patient under AME
The study team makes the final eligibility decision.
Where it's taking place
- Paris, Île-de-France Region, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, Île-de-France Region, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.